Seeto Reginald 4
4 · CareDx, Inc. · Filed Feb 3, 2023
Insider Transaction Report
Form 4
CareDx, Inc.CDNA
Seeto Reginald
See Remarks
Transactions
- Award
Common Stock
2023-02-01+302,000→ 569,152 total - Sale
Common Stock
2023-02-02$17.50/sh−503$8,805→ 575,803 total - Tax Payment
Common Stock
2023-02-02$17.61/sh−7,244$127,567→ 568,559 total - Tax Payment
Common Stock
2023-02-03$16.54/sh−1,228$20,311→ 566,103 total - Tax Payment
Common Stock
2023-02-01$15.66/sh−2,330$36,488→ 578,622 total - Sale
Common Stock
2023-02-02$17.07/sh−2,316$39,542→ 576,306 total - Award
Stock Option (right to buy)
2023-02-01+156,000→ 156,000 totalExercise: $15.66Exp: 2033-02-01→ Common Stock (156,000 underlying) - Award
Common Stock
2023-02-01+11,800→ 580,952 total - Tax Payment
Common Stock
2023-02-03$16.54/sh−1,228$20,311→ 567,331 total
Footnotes (8)
- [F1]The reported securities are represented by restricted stock units, 1/4th of which shall vest on February 1, 2024 and 1/4th of which shall vest on each anniversary thereafter.
- [F2]Includes 177 shares acquired on January 2, 2023 pursuant to the Issuer's 2014 Employee Stock Purchase Plan.
- [F3]The reported securities were subject to a performance restricted stock unit award that was initially granted on February 3, 2021 for a two-year performance period over calendar years 2021 and 2022, which performance was assessed and finalized effective February 1, 2023. 50.00% of the reported securities vested on February 1, 2023 and 50% of the reported securities will vest on December 31, 2023, subject to the Reporting Person's continued service with the Issuer.
- [F4]These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations in connection with the issuance of shares upon the vesting of restricted stock units.
- [F5]This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
- [F6]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.40 to $17.34, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased or sold at each separate price.
- [F7]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.44 to $17.61, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased or sold at each separate price.
- [F8]1/4th of the shares subject to the option shall vest on February 2, 2024 and 1/48th of the shares subject to the option shall vest monthly thereafter.